111 related articles for article (PubMed ID: 37625840)
1. Circular RNA SMARCA5 Promotes a Poor Prognosis and Radiotherapy Resistance for Patients with Hepatocellular Carcinoma.
Chang Z; Song Y; Luo F; Yang X; Cai Y; Guo H
Ann Clin Lab Sci; 2023 Jul; 53(4):573-577. PubMed ID: 37625840
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
[TBL] [Abstract][Full Text] [Related]
4. Application of Circular RNA Circ_0071662 in the Diagnosis and Prognosis of Hepatocellular Carcinoma and Its Response to Radiotherapy.
Wang X; Zhang J; Luo F; Shen Y
Dig Dis; 2023; 41(3):431-438. PubMed ID: 36279855
[TBL] [Abstract][Full Text] [Related]
5. Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma.
Li Z; Zhou Y; Yang G; He S; Qiu X; Zhang L; Deng Q; Zheng F
Clin Chim Acta; 2019 May; 492():37-44. PubMed ID: 30716279
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA cSMARCA5 regulates the progression of cervical cancer by acting as a microRNA‑432 sponge.
Huang P; Qi B; Yao H; Zhang L; Li Y; Li Q
Mol Med Rep; 2020 Mar; 21(3):1217-1223. PubMed ID: 31922210
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0006091 as a novel biomarker for hepatocellular carcinoma.
Zhang Y; Li J; Cui Q; Hu P; Hu S; Qian Y
Bioengineered; 2022 Feb; 13(2):1988-2003. PubMed ID: 35068348
[TBL] [Abstract][Full Text] [Related]
11. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA hsa_circ_0000437 may be used as a new indicator for the diagnosis and prognosis of hepatocellular carcinoma.
Chen G; Xie D; Zhang P; Zhou H
Bioengineered; 2022 Jun; 13(6):14118-14124. PubMed ID: 35730467
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.
Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H
BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.
Cheng F; Wang L; Zhang J
J Clin Lab Anal; 2020 Jul; 34(7):e23300. PubMed ID: 32319701
[TBL] [Abstract][Full Text] [Related]
15. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
Jiang T; Zhang XS; Pan F; Lyu SC; Wang J; Huang MX; He Q; Lang R
Medicine (Baltimore); 2021 Jul; 100(26):e26487. PubMed ID: 34190174
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of circRNA cSMARCA5 in patients with acute myocardial infarction].
Zhao JW; Yu HY; Zhang YZ; Gao W
Zhonghua Yi Xue Za Zhi; 2023 Mar; 103(12):901-906. PubMed ID: 36973217
[No Abstract] [Full Text] [Related]
17. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
18. circ_0067934: A Potential Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
Zhou C; Li R; Mi W
Ann Clin Lab Sci; 2020 Nov; 50(6):734-738. PubMed ID: 33334787
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated circ_0004913, circ_0008160, circ_0000517, and their potential as biomarkers for disease monitoring and prognosis in hepatocellular carcinoma.
Li X; Yang J; Yang X; Cao T
J Clin Lab Anal; 2021 Jun; 35(6):e23785. PubMed ID: 34018640
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
